BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30521797)

  • 1. Rare lesion in the uterine cervix with irregular vaginal bleeding.
    Jia QN; Fang K; Liu YH
    Am J Obstet Gynecol; 2019 Jun; 220(6):598-599. PubMed ID: 30521797
    [No Abstract]   [Full Text] [Related]  

  • 2. Papular-purpuric "gloves and socks" syndrome in systemic mastocytosis treated with imatinib: a diagnostic challenge.
    Jaworek AK; Sacha T; Woźniak-Knop M; Hałubiec P; Giza A; Wojas-Pelc A
    Pol Arch Intern Med; 2024 Jun; 134(6):. PubMed ID: 38640058
    [No Abstract]   [Full Text] [Related]  

  • 3. Primary histiocytic sarcoma of the uterine cervix: an extremely rare entity.
    Binesh F; Karimi-Zarchi M; Vahidfar MR; Hadgiabadi ZK
    Rom J Intern Med; 2017 Mar; 55(1):53-56. PubMed ID: 27828780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Well-differentiated systemic mastocytosis with KIT K509I mutation and uterus infiltration in an Asian woman with good response to imatinib.
    Zhao DD; Zhang L; Li WQ; Duan MH; Zhuang JL; Zhou DB
    Chin Med J (Engl); 2019 Aug; 132(16):2002-2003. PubMed ID: 31335472
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimal invasive treatment of cervical rhabdomyosarcoma in an adolescent girl.
    Stankovic ZB; Djuricić S; Stanković DS; Zdravković S; Gazikalović S; Sedlecki K
    J BUON; 2007; 12(1):121-3. PubMed ID: 17436413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epithelioid leiomyosarcoma of the uterine cervix: two cases].
    Chargui R; Bouzid T; Khomsil F; Damak T; Hassouna JB; Mtaallah M; Dhieb T; Gamoudi A; Boussen H; Hechiche M; Rahal K
    Tunis Med; 2007 Nov; 85(11):963-6. PubMed ID: 19166150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics of patients with mucinous adenocarcinoma of the uterine cervix: A retrospective study of 21 cases.
    Bonin L; Devouassoux-Shisheboran M; Golfier F
    J Gynecol Obstet Hum Reprod; 2019 May; 48(5):319-327. PubMed ID: 30807852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib mesylate for aggressive systemic mastocytosis with long bone osteolysis.
    Jung AG; Horny HP; Sotlar K; Overbeck T; Schön MP; Lippert U
    J Am Acad Dermatol; 2011 Jul; 65(1):224-6. PubMed ID: 21679828
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rare case of a cervix of uterus adenosarcome reported on a primipara 29 years old woman].
    Tomaszewski A; Michels JJ
    Ann Pathol; 2013 Jun; 33(3):222-4. PubMed ID: 23790667
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital.
    Horan RF; Austen KF
    J Invest Dermatol; 1991 Mar; 96(3 Suppl):5S-13S; discussion 13S-14S, 60S-65S. PubMed ID: 16799602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular response to imatinib in KIT F522C-mutated systemic mastocytosis.
    Broderick V; Waghorn K; Langabeer SE; Jeffers M; Cross NCP; Hayden PJ
    Leuk Res; 2019 Feb; 77():28-29. PubMed ID: 30612056
    [No Abstract]   [Full Text] [Related]  

  • 12. [Emergency embolization in gynaecological bleeding. Two case reports].
    Hatremi R; Sameh A; Azza S; Najla M; Rym BH; Sami M; Faouzia Z; Radhi H
    Tunis Med; 2005 Aug; 83(8):492-4. PubMed ID: 16238279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant trials can accelerate research on novel systemic treatment modalities in cancer of the uterine cervix.
    van Dam PA; Rolfo C; Ruiz R
    Eur J Surg Oncol; 2017 Dec; 43(12):2245-2247. PubMed ID: 29029937
    [No Abstract]   [Full Text] [Related]  

  • 14. [Primary hormone treatment or curettage in pathological uterine hemorrhages?].
    Kaiser R
    Munch Med Wochenschr; 1967 Jan; 109(1):10-5. PubMed ID: 6071803
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic challenge during the long-term follow-up of a patient with indolent systemic mastocytosis with extensive cutaneous involvement.
    Marton I; Pósfai É; Borbényi Z; Bödör C; Papp G; Demeter J; Korom I; Varga E; Bata-Csörgő Z
    Eur Rev Med Pharmacol Sci; 2015; 19(9):1607-9. PubMed ID: 26004600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of metrorragias after the menopause in the diagnosis of uterine cancer].
    Da Silva Carvalho J
    Arq Patol; 1967 Dec; 39(3):127-30. PubMed ID: 5622931
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systemic mastocytosis--rare cause of pathologic vertebral fracture].
    Stamm AC; Burbelko M; Rominger M
    Rofo; 2008 Jan; 180(1):57-9. PubMed ID: 17968773
    [No Abstract]   [Full Text] [Related]  

  • 18. Complete response after imatinib mesylate therapy in a patient with well-differentiated systemic mastocytosis.
    Alvarez-Twose I; González P; Morgado JM; Jara-Acevedo M; Sánchez-Muñoz L; Matito A; Mollejo M; Orfao A; Escribano L
    J Clin Oncol; 2012 Apr; 30(12):e126-9. PubMed ID: 22370312
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metrorrhagia disclosing a synchronous bilateral breast cancer: report of a case].
    Benkerroum Z; Babahabib A; Kouach J; Chahdi H; Al Bouzidi A; Moussaoui Rehali D; Dehayni M
    Gynecol Obstet Fertil; 2014 May; 42(5):360-4. PubMed ID: 24411296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic mastocytosis].
    Shi J; Li CL; Xu T
    Zhonghua Er Ke Za Zhi; 2005 Apr; 43(4):317-8. PubMed ID: 15924739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.